Alpelisib is an inhibitor designed for the treatment of HR /HER2breast cancer that carries PIK3CA mutations. It focuses on the PI3K signaling pathway like a bullseye. You’ve got choices of tablets in 50 mg, 200 mg, and 300 mg sizes.
The go-to dosage is 300 mg taken every day, and you’re supposed to eat something while you take it. The tablets come in packs, each with 28 tabs.
